The controlled-release oxycodone tablet formulation (OCRT) was approved in China in 2004 for management of moderate to severe cancer pain. Few data about the efficacy of OCRT and clinical outcomes ...

The FDA notes the following OxyContin drug interactions: The American Addiction Centers and NDIC say OxyContin ...

Researchers from three universities in the Polish Baltic city of Gdańsk have developed a new crystalline form of ...

which may be costly and inconvenient for certain patients (1 Trusted Source Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 ...

A slow-release, tablet form of ketamine with minimal side ... institutions in Australia and New Zealand to run a randomised-controlled trial testing the effectiveness of ketamine tablets to ...

This was an open-label, multicentre trial. Ten hospitals participated in this trial. It was approved by the investigators' institutional review board. The study was carried out in accordance with ...